A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival.

Roger Dmochowski, M.D., professor of Urologic Surgery at Vanderbilt University Medical Center, was recently elected a trustee of the American Board of Urology.

Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery at Vanderbilt University Medical Center, was recently named a representative on the Commission on Cancer.

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.

David Penson, M.D., the Paul V. Hamilton, M.D. and Virginia E. Howd Professor of Urologic Oncology, will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015.

More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat.